Synergy Care Group Ltd 14906025 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the development of care homes. Digita Accounts Production Advanced 6.30.9574.0 true false true false false false false 14906025 2024-04-01 2025-03-31 14906025 2025-03-31 14906025 bus:Consolidated 2025-03-31 14906025 core:RetainedEarningsAccumulatedLosses 2025-03-31 14906025 core:ShareCapital 2025-03-31 14906025 core:CurrentFinancialInstruments 2025-03-31 14906025 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 14906025 core:AdditionsToInvestments 2025-03-31 14906025 core:CostValuation 2025-03-31 14906025 core:FurnitureFittingsToolsEquipment 2025-03-31 14906025 bus:SmallEntities 2024-04-01 2025-03-31 14906025 bus:Audited 2024-04-01 2025-03-31 14906025 bus:FilletedAccounts 2024-04-01 2025-03-31 14906025 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 14906025 bus:RegisteredOffice 2024-04-01 2025-03-31 14906025 bus:Director1 2024-04-01 2025-03-31 14906025 bus:Director2 2024-04-01 2025-03-31 14906025 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14906025 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 14906025 core:LeaseholdImprovements 2024-04-01 2025-03-31 14906025 core:OfficeEquipment 2024-04-01 2025-03-31 14906025 core:PlantMachinery 2024-04-01 2025-03-31 14906025 core:KeyManagementPersonnel 2024-04-01 2025-03-31 14906025 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-04-01 2025-03-31 14906025 core:Subsidiary1 2024-04-01 2025-03-31 14906025 core:Subsidiary1 1 2024-04-01 2025-03-31 14906025 core:Subsidiary2 2024-04-01 2025-03-31 14906025 core:Subsidiary2 1 2024-04-01 2025-03-31 14906025 core:Subsidiary3 2024-04-01 2025-03-31 14906025 core:Subsidiary3 1 2024-04-01 2025-03-31 14906025 core:Subsidiary4 2024-04-01 2025-03-31 14906025 core:Subsidiary4 1 2024-04-01 2025-03-31 14906025 countries:EnglandWales 2024-04-01 2025-03-31 14906025 2024-03-31 14906025 core:RetainedEarningsAccumulatedLosses 2024-03-31 14906025 core:ShareCapital 2024-03-31 14906025 core:CurrentFinancialInstruments 2024-03-31 14906025 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14906025 core:CostValuation 2024-03-31 14906025 core:FurnitureFittingsToolsEquipment 2024-03-31 14906025 2023-05-31 2024-03-31 14906025 2024-03-31 14906025 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14906025 core:Subsidiary1 1 2023-05-31 2024-03-31 14906025 core:Subsidiary2 1 2023-05-31 2024-03-31 14906025 core:Subsidiary3 1 2023-05-31 2024-03-31 14906025 core:Subsidiary4 1 2023-05-31 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 14906025

Prepared for the registrar

Synergy Care Group Ltd

Annual Report and Financial Statements

for the Year Ended 31 March 2025

 

Synergy Care Group Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 7

 

Synergy Care Group Ltd

Company Information

Directors

S T Day

N J Patel

Registered office

Argyle House
Joel Street
Northwood
HA6 1NW

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Synergy Care Group Ltd

(Registration number: 14906025)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

200

-

Investments

5

4

1

 

204

1

Current assets

 

Debtors

6

438,488

560

Cash at bank and in hand

 

10,614

751

 

449,102

1,311

Creditors: Amounts falling due within one year

7

(470,788)

(5,012)

Net current liabilities

 

(21,686)

(3,701)

Net liabilities

 

(21,482)

(3,700)

Capital and reserves

 

Called up share capital

101

101

Profit and loss account

(21,583)

(3,801)

Shareholders' deficit

 

(21,482)

(3,700)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 December 2025 and signed on its behalf by:
 


N J Patel
Director

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Argyle House
Joel Street
Northwood
HA6 1NW

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Acacia Care Investments Limited.

The financial statements of Acacia Care Investments Limited may be obtained from Companies House.

Group accounts not prepared

The company has taken advantage of the exemption in section 398 of the Companies Act 2006 from the requirement to prepare consolidated financial statements, on the grounds that it is a small group.

Going concern

Notwithstanding the net liability position shown on the balance sheet, the financial statements have been prepared on the going concern basis. The directors have considered the forecast cash flows and the cash requirements of the business in their assessment of going concern. As a result of this assessment it was concluded that the cash requirements of the business for the 12 months from signing will be met through a combination of operational cash flows and intergroup loans and thus the business is deemed to operate as a going concern.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold property

Over the life of the lease

Plant and machinery

10% straight line

Office equipment

25%-33% straight line

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

Subsidiaries

£

Cost and carrying amount

At 1 April 2024

1

Additions

3

At 31 March 2025

4

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2025

2024

Subsidiary undertakings

Synergy Care Developments Ltd

England and Wales

Ordinary

100%

100%

Acacia Care (Hunstanton) Limited

England and Wales

Ordinary

100%

100%

Acacia Care (NL) Limited

England and Wales

Ordinary

100%

100%

Synergy Care Developments (Radcliffe) Limited

England and Wales

Ordinary

100%

100%

The principal activity of Synergy Care Developments Ltd is that of a property development company. Acacia Care (Hunstanton) Ltd, Acacia Care (NL) Ltd and Synergy Care Developments (Radcliffe) Ltd will become care operating companies once developments undertaken in Synergy Care Developments Ltd are completed.

All subsidiary undertakings have the same registered office as Synergy Care Group Ltd.

 

Synergy Care Group Ltd

Notes to the Financial Statements for the Year Ended 31 March 2025

 

6

Debtors

2025
£

2024
£

Amounts owed by group undertakings

216,281

-

Other debtors

222,207

560

438,488

560

 

7

Creditors

2025
£

2024
£

Due within one year

Trade creditors

900

-

Amounts due to group undertakings

469,888

5,012

470,788

5,012

 

8

Related party transactions

Loans to related parties

2025

Directors
£

Advanced

200,000

Terms of loans to related parties

During the year the company lent £200,000 to a director. The amount is outstanding at the year end. This is the largest amount outstanding during the year. The loan is interest free and no fixed repayment terms have been agreed.
 

 

9

Parent and ultimate parent undertaking

The company's immediate parent is Acacia Care Investments Ltd, incorporated in England and Wales.

 The ultimate controlling party is the director, N J Patel.

 

10

Disclosure under Section 444 (5B) CA 2006 relating to the independent auditor's report

As permitted by Section 444 CA 2006, these accounts do not contain a copy of the company’s Profit and Loss account or a copy of the Directors’ Report. Accordingly, the Independent Auditors’ Report has also been omitted.

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 16 December 2025 was Joanne Hartness, who signed for and on behalf of Hazlewoods LLP.